The U.S. Food and Drug Administration has approved Omeros' drug for a dangerous transplant complication in adults and ...
Precious metals were the clear winner in 2025, while pretty much all other traditional "safe haven" investments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback